The FDA-approved label for Lunesta (eszopiclone) does not specify how long the medication can be used to treat insomnia. Lunesta has been studied for up to 12 months in people with chronic insomnia, where it has been proven to work well during this time.Continue reading ...
See FDA-approved patient labeling (PATIENT INFORMATION). Inform patients and their families about the benefits and risks of treatment with LUNESTA. Inform patients of the availability of a Medication Guide and instruct them to read the Medication Guide prior to initiating treatment with LUNESTA and ...